# SOLITARY PULMONARY NODULE

## Principles

• 定義: single, well-defined, <3 cm, surrounded by 正常 lung, no LAN or pleural effusion

• Often “incidentalomas,” esp with ↑ CT use, but may still be early, curable malignancy

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p>原因</p></td></tr><tr><td><p><b>Benign</b> (<b>70%</b>)</p></td><td><p><b>Malignant</b> (<b>30%</b>)</p></td></tr><tr><td><p><b>Granuloma</b> (80%): TB, histo, coccidio</p><p><b>Hamartoma</b> (10%)</p><p>Bronchogenic cyst, AVM, pulm infarct</p><p>Echinococcosis, ascariasis, aspergilloma</p><p>GPA, rheumatoid nodule, sarcoidosis</p><p>Lipoma, fibroma, amyloidoma</p></td><td><p><b>Bronchogenic carcinoma</b> (75%) periph: adeno (most common) &amp; large cell central: squamous &amp; small cell</p><p><b>Metastatic</b> (20%): sarcoma, melanoma, breast, head &amp; neck, colon, testicular, renal</p><p>Carcinoid, primary sarcoma</p></td></tr></tbody></table>

## Initial evaluation

• **History:** h/o cancer, smoking, age (<30 y = 2% malignant, +15% each decade >30)

• **CT:** size/shape, Ca2+, LAN, effusions, bony destruction, **compare with old studies**

∅ Ca → ↑ likelihood malignant; laminated → granuloma; “popcorn” → hamartoma

• High-risk features for malig: size (eg, ≥2.3 cm diameter), spiculated, upper lobe, ♀, >60 yo, >1 ppd current smoker, no prior smoking cessation (_NEJM_ 2003;348:2535 & 2013;369:910)

## Diagnostic studies

• **PET:** detects metabolic activity of tumors, 97% Se & 78% Sp for malig (esp if >8 mm)

useful for surgical staging b/c may detect unsuspected mets (_JAMA_ 2001;285:914)

useful in deciding which lesions to bx vs. follow with serial CT (_J Thor Oncol_ 2006;1:71)

• **Transthoracic needle biopsy** (TTNB): if tech feasible, 97% will obtain definitive tissue dx (_AJR_ 2005;185:1294); if noninformative or malignant → resect

• **Video-assisted thoracoscopic surgery** (VATS): for percutaneously inaccessible lesions; highly sensitive and allows resection; has replaced thoracotomy

• Transbronchial bx (TBB): most lesions too small to reliably sample without endobronchial

U/S (_Chest_ 2003;123:604); bronch with brushings low-yield unless invading bronchus;

navigational bronchoscopy with 70% yield, ↑ sens with larger nodules (_Chest_ 2012;142:385)

• PPD, fungal serologies, ANCA

## Management (if >8 mm; if ≤8 mm, serial CT q6-12mo) (_Chest_ 2013;143:840)

• **Low risk** (<5%, see ref): serial CT (freq depending on risk); shared decision with Pt re: bx

• **Intermediate risk** (5–60%): PET; if → follow low-risk protocol, if ⊕ → high-risk protocol

• **High risk** (and surgical candidate): TBB, TTNB, or VATS → lobectomy if malignant

• **Ground-glass nodules:** longer f/u (b/c if malignant can be slow-growing) & PET
